Children as young as 2 years old have started to receive Pfizer’s COVID-19 vaccine Wednesday as part of a trial by Stanford medical researchers, according to CBS San Francisco.
“We need to make sure that children are protected,” Dr. Yvonne Maldonado told the San Francisco Chronicle. “There’s been over 3 million children infected, thousands hospitalized and almost 300 deaths. Even though it’s not the half million-plus adult deaths we’ve seen, we’ve seen an impact in children.”
Kids between the ages of 2 and 5 are eligible, according to reports.
According to the Chronicle, 144 participants have already signed up for phase 1 of the trials.
Almost 3.5 million kids have been infected with the disease and 347 children have died, according to the American Academy of Pediatrics.
This summer, Stanford will have a larger trial for children between the ages of 5-12.